Cargando…
Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
BACKGROUND: Glutathione S-transferase omega-1 and 2 genes (GSTO1, GSTO2), residing within an Alzheimer and Parkinson disease (AD and PD) linkage region, have diverse functions including mitigation of oxidative stress and may underlie the pathophysiology of both diseases. GSTO polymorphisms were prev...
Autores principales: | Allen, Mariet, Zou, Fanggeng, Chai, High Seng, Younkin, Curtis S, Miles, Richard, Nair, Asha A, Crook, Julia E, Pankratz, V Shane, Carrasquillo, Minerva M, Rowley, Christopher N, Nguyen, Thuy, Ma, Li, Malphrus, Kimberly G, Bisceglio, Gina, Ortolaza, Alexandra I, Palusak, Ryan, Middha, Sumit, Maharjan, Sooraj, Georgescu, Constantin, Schultz, Debra, Rakhshan, Fariborz, Kolbert, Christopher P, Jen, Jin, Sando, Sigrid B, Aasly, Jan O, Barcikowska, Maria, Uitti, Ryan J, Wszolek, Zbigniew K, Ross, Owen A, Petersen, Ronald C, Graff-Radford, Neill R, Dickson, Dennis W, Younkin, Steven G, Ertekin-Taner, Nilüfer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393625/ https://www.ncbi.nlm.nih.gov/pubmed/22494505 http://dx.doi.org/10.1186/1750-1326-7-13 |
Ejemplares similares
-
Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
por: Zou, Fanggeng, et al.
Publicado: (2012) -
LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013) -
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014) -
Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
por: Carrasquillo, Minerva M, et al.
Publicado: (2011) -
Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)